Live Breaking News & Updates on Research institute for biological safety problems

Stay informed with the latest breaking news from Research institute for biological safety problems on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Research institute for biological safety problems and stay connected to the pulse of your community

Kazakhstan to Produce Own Version of Sputnik V Vaccine

February 15, 2021 • 10:17 am CST
(Precision Vaccinations)
The Karaganda Pharmaceutical Complex, located in Karaganda, Kazakhstan, announced on February 15, 2021, plans to leverage the Sputnik V vaccine to produce the QazCovid-In Vaccine, reported TASS.
This COVID-19 vaccine candidate is currently undergoing a phase 3 clinical study sponsored by Research Institute for Biological Safety Problems. This study's estimated Primary Completion Date is March 31, 2021.
On February 1st, Kazakhstan began its coronavirus vaccination campaign by administering the Sputnik V vaccine, which is authorized in about 26 countries.
The COVID-19 vaccine Sputnik V (Gam-COVID-Vac) is an adenoviral-based vaccine against the SARS-CoV-2 coronavirus. Sputnik V uses a weakened virus to deliver small parts of a pathogen and stimulate an immune response.

Kazakhstan , Research-institute-for-biological-safety-problems , Precision-vaccinations , Pharmaceutical-complex , Qazcovid-in-vaccine , Research-institute , Biological-safety , Primary-completion-date , காஸக்ஸ்டாந் , ஆராய்ச்சி-நிறுவனம்-க்கு-உயிரியல்-பாதுகாப்பு-ப்ராப்லம்ஸ் , ப்ரிஸிஶந்-தடுப்பூசிகள்

Kazakhstan to begin mass vaccination against COVID-19 from March 2021 - Xinhua

Kazakhstan to begin mass vaccination against COVID-19 from March 2021 - Xinhua
xinhuanet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from xinhuanet.com Daily Mail and Mail on Sunday newspapers.

Kazakhstan , Zhambyl , Askar-mamin , Research-institute-for-biological-safety-problems , Kazakh-prime-minister-askar-mamin , Research-institute , Biological-safety-problems , Zhambyl-region , காஸக்ஸ்டாந் , அஸ்கர்-மாமின் , ஆராய்ச்சி-நிறுவனம்-க்கு-உயிரியல்-பாதுகாப்பு-ப்ராப்லம்ஸ் , க்யாஸ்யாக்-ப்ரைம்-அமைச்சர்-அஸ்கர்-மாமின்

Kazakhstan to begin mass vaccination against COVID-19 from March 2021

Kazakhstan to begin mass vaccination against COVID-19 from March 2021
azerbaijannews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from azerbaijannews.net Daily Mail and Mail on Sunday newspapers.

Kazakhstan , Zhambyl , Askar-mamin , Research-institute-for-biological-safety-problems , Kazakh-prime-minister-askar-mamin , Research-institute , Biological-safety-problems , Zhambyl-region , காஸக்ஸ்டாந் , அஸ்கர்-மாமின் , ஆராய்ச்சி-நிறுவனம்-க்கு-உயிரியல்-பாதுகாப்பு-ப்ராப்லம்ஸ் , க்யாஸ்யாக்-ப்ரைம்-அமைச்சர்-அஸ்கர்-மாமின்

Factory in Zhambyl region to produce 30 to 60 million doses of vaccines

02.12.2020 16:24
7678
This year, coronavirus express testing kits manufacturing factory is planned to be launched in Zhambyl region. The investment project costs more than two billion tenge. The regional governor Berdibek Saparbayev spoke about the measures to fight against the spread of dangerous infection at a briefing in the Central Communications Service. Accroding to him, it is planned to build anti-viral vaccine manufacturing factory in Kordai district of Zhambyl region. This project costs seven billion tenge. The factory is expected to operate on the basis of the Research Institute for Biological Safety Problems.
Currently, vaccines against brucellosis, dermatitis and avian influenza are produced. A new additional factory will be launched. Its capacity will total at least 30 - 60 million doses of coronavirus vaccines. The factory is planned to be launched by the end of the year. Vaccine manufacturing will start in March. Government supports and controls this issue. Residential building will be constructed for workers, said the Governor of Zhambyl Region Berdibek Saparbayev.

Berdibek-saparbayev , Research-institute-for-biological-safety-problems , Central-communications-service , Central-communications , Research-institute , Biological-safety , Zhambyl-region-berdibek , ஆராய்ச்சி-நிறுவனம்-க்கு-உயிரியல்-பாதுகாப்பு-ப்ராப்லம்ஸ் , மைய-தகவல்தொடர்புகள்-சேவை , மைய-தகவல்தொடர்புகள் , ஆராய்ச்சி-நிறுவனம் , உயிரியல்-பாதுகாப்பு